Merrimack Pharmaceuticals, Inc.
ANTI-TNFR2 ANTIBODIES AND USES THEREOF

Last updated:

Abstract:

Anti-TNFR2 antibodies which bind to particular human TNFR2 epitopes, therapeutic compositions comprising the anti-TNFR2 antibodies, and methods of using such antibodies and compositions in the treatment of cancer are disclosed.

Status:
Application
Type:

Utility

Filling date:

18 Sep 2019

Issue date:

2 Dec 2021